Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Barouch: Novel Vector/Protein Vaccines |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2014-05-13 |
| Study Made Public: | 2016-01-15 |
Title
NAb responses elicited by ChAd24, RhAd52, and RhAd35 vectors expressing 459C Env gp140, all followed by a 459C Env gp140/AS01B boost
Description
CAVD 453 is a non-human primate challenge study comparing neutralizing antibody responses in simian adenovirus/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.